In particular, we demonstrated that pathogenetic T cells from MOG-induced experimental autoimmune encephalomyelitis (EAE) mice showed diminished TSPAN32 levels in comparison to irrelevant T cells, and that following activation, CD4 T cells from MS patients had significantly lower mRNA levels of TSPAN32 [8]. This evidence concerns the gene CD4 and myeloid sarcoma.